Skip to content

Intra-articular platelet-rich plasma vs corticosteroids in the treatment of moderate knee osteoarthritis

Intra-articular platelet-rich plasma vs corticosteroids in the treatment of moderate knee osteoarthritis: a single-center prospective randomized controlled study with a one-year follow up

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN46024618
Enrollment
40
Registered
2019-09-16
Start date
2016-04-01
Completion date
Unknown
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis Musculoskeletal Diseases Knee osteoarthritis

Interventions

Patients suffering knee pain were redirected to the one physician of the clinical team involved in the trial who evaluated suitability. Patients who met inclusion criteria were divide

Sponsors

ORTO KLINIKA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients older than 55 years with a history of chronic pain, swelling and/or reduced range of motion in the knee joint 2. Clinical and radiological confirmation of OA of the knee (Kellgren – Lawrence KL grades II-III) was verified by assessing X-Ray images in anteroposterior and lateral projections

Exclusion criteria

Exclusion criteria: 1. Posttraumatic knee 2. Pregnancy, breastfeeding 3. Oncological diseases 4. Endocrine diseases (gout, diabetes) 5. Autoimmune diseases (rheumatoid arthritis) 6. Acute/chronic infectious disease, blood clotting disorders (thrombocytopenia, coagulopathy) 7. Previous interventions on the knee joint (i.e. punctures, blockades, arthroscopy) 8. Received consistent hormonal therapy or non-steroidal anti-inflammatory drugs (NSAIDs) within 10 days prior to the intervention

Design outcomes

Primary

MeasureTime frame
Pain VAS score at 1 year (change from baseline)

Secondary

MeasureTime frame
1. International Knee Documentation Committee (IKDC 2000 form) scale and Knee Society Score (KSS) at any time point: one week (V2), 5 weeks (V3), 15 weeks (V4) and 30 weeks (V5). 2. VAS scores at short-term (1 week)

Countries

Latvia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 26, 2026